Table 5.
Clinical manifestation of co-infected patients in case reports/case series studies among a total of 29 evaluated patients.
| Variables | Number of studies | n* (%) |
|---|---|---|
| Cough | 11 | 23 (79.3) |
| Fever | 14 | 26 (89.4) |
| Respiratory distress | 1 | 1 (3.4) |
| Dyspnoea | 3 | 6 (20.7) |
| Tachypnoea | 2 | 5 (17.2) |
| Bronchospasm | 1 | 4 (13.8) |
| Sputum production | 2 | 2 (6.9) |
| Gastrointestinal symptoms | 2 | 2 (6.9) |
| Malaise | 2 | 2 (6.9) |
| Headache | 2 | 5 (17.2) |
| Shortness of breath | 4 | 7 (24.1) |
| Body pain | 1 | 2 (6.9) |
| Myalgia | 5 | 6 (20.7) |
*
n, number of co-infected patients with any variables.